OTCM
LRLCF
Market cap241bUSD
, Last price
Name
L'Oreal SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
L'Oréal S.A., a leading global beauty enterprise, manufactures and markets a comprehensive array of cosmetic items for male and female consumers across the globe, operating through its subsidiaries. The company structures its vast operations into four primary segments: Consumer Products, L'Oréal Luxe, Professional Products, and Active Cosmetics. Its diverse product portfolio encompasses hair care (including shampoos, styling aids, and colorants), skin care (cleansers, moisturizers, sun protection), body care (shower gels, deodorants), an extensive make-up range, and various fragrances. L'Oréal owns a vast collection of well-known brands, such as L'Oréal Paris, Garnier, Maybelline New York, Lancôme, Yves Saint Laurent Beauté, Kiehl's, Vichy, La Roche-Posay, and CeraVe, among numerous others, catering to a wide spectrum of market demands. These offerings are distributed through a broad global network, including professional hair salons, mass-market retail outlets, high-end perfumeries, department stores, pharmacies, drugstores, medispas, dedicated branded stores, travel retail locations, and robust e-commerce platforms. Established in 1909, L'Oréal S.A. is headquartered in Clichy, France.
Related entities
Subsidiaries (60)
BOLD BUSINESS OPPORTUNITIES FOR L'OREAL DEVELOPMENT
CANAN KOZMETIK SANAYI VE TICARET ANONIM ŞIRKETI
COBELSA COSMETICOS SA
Cosbel S.A. de C.V.
COSMELOR Ltd.
COSMETIQUE ACTIVE INTERNATIONAL
el-okei(yu)
ERWITON SOCIEDAD ANONIMA
FINVAL
Frabel S.A. de C.V.
Interbeauty Cosmetics Ltd.
L OREAL URUGUAY S A
L' OREAL HELLAS Α.Ε.
L' OREAL PORTUGAL, UNIPESSOAL LDA
L'OREAL (U.K.) LIMITED
L'OREAL AUSTRALIA PTY LTD
L'Oreal Belgilux
L'OREAL CANADA INC.
L'OREAL Ceska republika s.r.o.
L'OREAL CHILE S.A.
Key people
Chairman of the Board · since 2021
Nicolas Hieronimus
Chief Executive Officer, Member of the Executive Committee, Director · since 2021
Paul Bulcke
Vice Chairman of the Board · since 2017
Asmita Dubey
Chief Digital and Marketing Officer, Member of the Executive Committee · since 2021
Chief Financial Officer, Member of the Executive Committee · since 2020
Ezgi Barcenas
Chief Corporate Responsibility Officer and L'Oreal Foundation, Member of the Executive Committee · since 2024
Cyril Chapuy
President - Luxe, Member of the Executive Committee · since 2019
Myriam Cohen-Welgrym
Member of the Executive Committee, President - Dermatological Beauty · since 2022
Vianney Derville
Chief Growth Officer, Member of the Executive Committee · since 2026
Emmanuel Goulin
President - Travel Retail, Member of the Executive Committee · since 2024
David Greenberg
Member of the Executive Committee, President - North America. Chief Executive Officer L'Oreal USA · since 2022
Omar Hajeri
President - Professional Products, Member of the Executive Committee · since 2021
Blanca Juti
Member of the Executive Committee, Chief Corporate Affairs and Engagement Officer · since 2021
Barbara Lavernos
Deputy Chief Executive Officer - In charge of Research, Innovation and Technology, Member of the Executive Committee · since 2021
Jean-Claude Le Grand
Chief Human Relations Officer, Member of the Executive Committee · since 2020
Alexis Perakis-Valat
President - Consumer Products , Member of the Executive Committee · since 2016
Ersi Pirishi
President, Latin America Zone, Member of the Executive Committee · since 2021
Vismay Sharma
President, South Asia, Pacific, Middle East and North Africa Zones, Member of the Executive Committee · since 2020
Antoine Vanlaeys
Chief Operations Officer, Member of the Executive Committee · since 2021
Eva Yu
President - Travel Retail, Member of the Executive Committee · since 2026
Headquarters & legal address
14 RUE ROYALE
PARIS 75008
FR
PARIS 75008
FR
Trading name
KERASTASE ; MIZANI ; L'OREAL PROFESSIONNEL PARIS ; ESSIE PROFESSIONNEL ; BAXTER OF CALIFORNIA ; BIOL
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||